Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Seagen Inc.
  6. News
  7. Summary
    SGEN   US81181C1045

SEAGEN INC.

(SGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about SEAGEN INC.
06/03SEAGENá : Announces Long-Term Results from TUKYSA« (tucatinib) Pivotal Trial in ..
BU
06/02SEAGENá : to Present at the Goldman Sachs 42nd Annual Global Healthcare Conferen..
BU
05/18INSIDER TRENDS : Seagen Insider Receives Stock Award and Converts/Exercises Deri..
MT
05/17SEAGENá : Evercore ISI Initiates Coverage on Seagen With In-Line Rating, $153 Pr..
MT
05/13INSIDER TRENDS : Insider Sale at Seagen Slowing 90-Days of Buying
MT
04/30SEAGENá : Berenberg Bank Adjusts Seagen PT to $197 From $208, Maintains Buy Rati..
MT
04/30SEAGENá : Oppenheimer Adjusts Seagen PT to $208 From $213, Maintains Outperform ..
MT
04/30SEAGENá : Piper Sandler Adjusts Seagen's Price Target to $160 From $170, Maintai..
MT
04/30SEAGENá : Credit Suisse Lowers Seagen's PT to $141 from $145 After In Line Q1 Re..
MT
04/30SEAGENá : RBC Capital Adjusts Seagen PT to $148 From $169 Following Dissapointin..
MT
04/29SEAGENá : to Showcase Data from Growing Oncology Portfolio During Virtual Scient..
BU
04/27SEAGENá : Five Rules For A Successful Supplementary Protection Certificate Appli..
AQ
04/19SEAGENá : Astellas' Biologics License Applications for Bladder Cancer Drug Candi..
MT
04/19SEAGENá : and Astellas Announce U.S. FDA Acceptance of Two Supplemental Biologic..
BU
04/09SEAGENá : and Genmab Announce U.S. FDA Filing Acceptance for Priority Review of ..
BU
More most relevant news
All news about SEAGEN INC.
06/07SPRINGWORKS THERAPEUTICSá : Seagen Working Together to Study Multiple Myeloma Co..
MT
06/03SEAGENá : Announces Long-Term Results from TUKYSA« (tucatinib) Pivotal Trial in ..
BU
06/02SEAGENá : to Present at the Goldman Sachs 42nd Annual Global Healthcare Conferen..
BU
05/20ASTELLAS PHARMAá : and Seagen Announce Updated Results from Two Trials of PADCEV..
AQ
05/20SEZARY SYNDROME PIPELINE : Emerging Therapies and Key pharma players involved by..
AQ
05/19SEAGEN INC.á : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/18INSIDER TRENDS : Seagen Insider Receives Stock Award and Converts/Exercises Deri..
MT
05/18Astellas to Present Data from Expanding Oncology Portfolio During the 2021 AS..
AQ
05/17SEAGENá : Evercore ISI Initiates Coverage on Seagen With In-Line Rating, $153 Pr..
MT
05/13INSIDER TRENDS : Insider Sale at Seagen Slowing 90-Days of Buying
MT
More news
News in other languages on SEAGEN INC.
2020US-Konzern Merck & Co übernimmt Krebsforscher Velosbio
202010 Biotechs qui font parler d'elles
2020Aktien New York Schluss: Übernahmen bescheren starken Wochenauftakt
2020Aktien New York: Übernahme-Welle sorgt für einen starken Wochenauftakt
2020DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 14.09.2020 - 15.15 Uhr
2020Aktien New York Ausblick: Übernahme-Welle heizt die Stimmung auf
2020US-Konzern Merck & Co steigt für Krebsmittelforschung bei Seattle Genetics ei..
2020GSKá : un groupe d'experts vote pour le traitement du myélome
2020GENMABá : le titre gagne 2%, après une étude positive
2020TIDJANE THIAM : KERING accueille Emma Watson et l'ancien DG de Credit Suisse à s..
More news
Analyst Recommendations on SEAGEN INC.
05/17SEAGENá : Evercore ISI Initiates Coverage on Seagen With In-Line Rating, $153 Pr..
MT
04/30SEAGENá : Berenberg Bank Adjusts Seagen PT to $197 From $208, Maintains Buy Rati..
MT
04/30SEAGENá : Oppenheimer Adjusts Seagen PT to $208 From $213, Maintains Outperform ..
MT
04/30SEAGENá : Piper Sandler Adjusts Seagen's Price Target to $160 From $170, Maintai..
MT
04/30SEAGENá : Credit Suisse Lowers Seagen's PT to $141 from $145 After In Line Q1 Re..
MT
More recommendations
Press releases
06/03SEAGENá : Announces Long-Term Results from TUKYSA« (tucatinib) Pivotal Trial in ..
BU
06/02SEAGENá : to Present at the Goldman Sachs 42nd Annual Global Healthcare Conferen..
BU
05/20ASTELLAS PHARMAá : and Seagen Announce Updated Results from Two Trials of PADCEV..
AQ
05/20SEZARY SYNDROME PIPELINE : Emerging Therapies and Key pharma players involved by..
AQ
05/19SEAGEN INC.á : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
More press releases
Upcoming event on SEAGEN INC.
07/29/21